Terawaki H - Search Results

1

Successful treatment of encapsulating peritoneal sclerosis by hemodialysis and peritoneal lavage using dialysate containing dissolved hydrogen.

Terawaki H, Nakano H, Zhu WJ, Nakayama M. Terawaki H, et al. Perit Dial Int. 2015 Jan-Feb;35(1):107-12. doi: 10.3747/pdi.2013.00255. Perit Dial Int. 2015. PMID: 25700467 Free PMC article. No abstract available.

2

[Significance of residual renal functions of patients with end-stage renal failure undergoing continuous ambulatory peritoneal dialysis].

Kasai K, Kobayashi H, Terawaki H, Hirano K, Ohtsuka Y, Kato N, Kawaguchi Y, Hosoya T. Kasai K, et al. Among authors: terawaki h. Nihon Jinzo Gakkai Shi. 1997 Dec;39(8):783-9. Nihon Jinzo Gakkai Shi. 1997. PMID: 9483944 Japanese.

3

[The impact of low calcium dialysate (1.25 mmol/l; LCD) on bone metabolism in CAPD patients].

Terawaki H, Kasai K, Kawaguchi Y, Kobayashi H, Hirano K, Ohtsuka Y, Hosoya T. Terawaki H, et al. Nihon Jinzo Gakkai Shi. 1998 May;40(4):252-7. Nihon Jinzo Gakkai Shi. 1998. PMID: 9654908 Japanese.

4

[Clinical evaluation of cases with massive ascites accumulation after discontinuation of CAPD: an attempt to establish the concept of the pre-sclerosing encapsulating peritonitis(pre-SEP) state].

Kasai K, Terawaki H, Otsuka Y, Hamaguchi A, Kondo M, Tanno Y, Hara Y, Ichinose M, Kawaguchi Y, Hosoya T. Kasai K, et al. Among authors: terawaki h. Nihon Jinzo Gakkai Shi. 2000 May;42(4):346-52. Nihon Jinzo Gakkai Shi. 2000. PMID: 10897594 Japanese.

5

Measurement of translymphatic fluid absorption using technetium-99m human serum albumin diethylenetriamine pentaacetic acid in continuous ambulatory peritoneal dialysis patients.

Terawaki H, Nakayama M, Seto K, Yoshimura K, Hasegawa T. Terawaki H, et al. Ther Apher Dial. 2004 Aug;8(4):305-12. doi: 10.1111/j.1526-0968.2004.00158.x. Ther Apher Dial. 2004. PMID: 15274682

6

Reduction of serum antioxidative capacity during hemodialysis.

Nakayama K, Terawaki H, Nakayama M, Iwabuchi M, Sato T, Ito S. Nakayama K, et al. Among authors: terawaki h. Clin Exp Nephrol. 2007 Sep;11(3):218-224. doi: 10.1007/s10157-007-0486-3. Epub 2007 Sep 28. Clin Exp Nephrol. 2007. PMID: 17891349

7

Transluminal replacement of displaced peritoneal catheter using a special "alpha-replacer" guidewire: effectiveness and limitations.

Terawaki H, Nakayama M, Nakano H, Hasegawa T, Ogura M, Hosoya T, Karino T. Terawaki H, et al. Perit Dial Int. 2007 Nov-Dec;27(6):702-6. Perit Dial Int. 2007. PMID: 17984435

8

Home blood pressure monitoring, even by the elderly, may save a kidney.

Terawaki H. Terawaki H. Hypertens Res. 2009 Dec;32(12):1055. doi: 10.1038/hr.2009.169. Epub 2009 Oct 16. Hypertens Res. 2009. PMID: 19834488 No abstract available.

9

Clinical impact of a combined therapy of peritoneal dialysis and hemodialysis.

Matsuo N, Yokoyama K, Maruyama Y, Ueda Y, Yoshida H, Tanno Y, Yamamoto R, Terawaki H, Ikeda M, Hanaoka K, Yamamoto H, Ogura M, Watanabe S, Kimura Y, Hosoya T. Matsuo N, et al. Among authors: terawaki h. Clin Nephrol. 2010 Sep;74(3):209-16. doi: 10.5414/cnp74209. Clin Nephrol. 2010. PMID: 20860905

10

The redox state of albumin and serious cardiovascular incidence in hemodialysis patients.

Terawaki H, Takada Y, Era S, Funakoshi Y, Nakayama K, Nakayama M, Ogura M, Ito S, Hosoya T. Terawaki H, et al. Ther Apher Dial. 2010 Oct;14(5):465-71. doi: 10.1111/j.1744-9987.2010.00841.x. Ther Apher Dial. 2010. PMID: 21175544

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results